Skip to main content

Table 1 Percentage of PC12 cells in each state after treatment with 6-OHDA, 6-OHDA + thymol 100 µM, 6-OHDA + thymol 150 µM. The data presented are mean ± SEM of two independent experiments

From: Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress

Compound/Concentration

Vital cells (%) An-/PI-

Early Apoptosis (%) An + /PI-

Late apoptosis (%) An + /PI + 

Necrosis

(%) An-/PI + 

Control

96.05 ± 0.75

0.23 ± 0.05

1.90 ± 0.67

1.64 ± 0.64

6-OHDA 75 μM

68.80 ± 3.00

2.10 ± 0.12

8.4 ± 1.1

27.80 ± 0.30

6-OHDA/Thymol 100 μM

79.90 ± 1.8

2.31 ± 0.79

5.92 ± 0.88

17.76 ± 2.36

6-OHDA/Thymol 150 μM

87.00 ± 2.7*

3.01 ± 0.98

6.59 ± 0.61

15.76 ± 2.96*

  1. p < 0.05 and ≈ p < 0.01 compared with control, *p < 0.05 compared with 6-OHDA